Indices of relative weight and obesity

Ancel Keys, Flaminio Fidanza, Martti J. Karvonen, +2

Journal of Chronic Diseases

ObesityWeight StatusNutritionChildhood ObesityRelative Weight +8

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Franck Pagès, Bernhard Mlecnik, Florence Marliot, +95

The Lancet

Prognostic BiomarkersOncologyInternational ValidationMedicineImmunology +10

THE DIET AND 15-YEAR DEATH RATE IN THE SEVEN COUNTRIES STUDY

Ancel Keys, ALESSANDRO MIENOTTI, MARITI J. KARVONEN, +12

American Journal of Epidemiology

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

Eriko Tateishi-Yuyama, Hiroaki Matsubara, Toyoaki Murohara, +10

The Lancet

Regenerative MedicineCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation +8

A new protein containing an SH2 domain that inhibits JAK kinases

Takaho A. Endo, Masaaki Masuhara, Masahiro Yokouchi, +14

Nature

Protein FunctionSignal TransductionSignaling PathwayNatural SciencesReceptor Tyrosine Kinase +10

Long-term Consequences of Kawasaki Disease

Hirohisa Kato, T. Sugimura, Teiji Akagi, +6

Circulation

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Haruhiko Yoshida, Yasushi Shiratori, Mitsuhiko Moriyama, +14

Annals of Internal Medicine

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region

Fumihiko Ishikawa, Shuro Yoshida, Yoriko Saito, +17

Nature Biotechnology

Regenerative MedicineCell TherapyMedicineStem Cell TransplantationBone-marrow Endosteal Region +8

Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)

Ichizo Nishino, Jin Fu, Kurenai Tanji, +16

Nature

OphthalmologyMedicinePathologyDanon DiseaseX-linked Vacuolar Cardiomyopathy +1

Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

Toyoaki Hida, Hiroshi Nokihara, Masashi Kondo, +20

The Lancet

MedicineRandomised Phase 3PathologyAlectinib Versus CrizotinibBronchial Neoplasm +6